Skip to main content
Xiusheng Qin, MD, Oncology, Lima, OH, Lima Memorial Health System

XiushengQinMDPhD

Oncology Lima, OH

Hematologic Oncology

Richmond Cancer Center

Dr. Qin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Qin's full profile

Already have an account?

Education & Training

  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Greater Baltimore Medical Center
    Greater Baltimore Medical CenterResidency, Internal Medicine, 2000 - 2003
  • University Hospitals Cleveland Medical Center
    University Hospitals Cleveland Medical Center1996 - 2000
  • The University of Tokyo
    The University of TokyoPh.D, Pathology, 1992 - 1996
  • Henan Medical University
    Henan Medical UniversityMA, Oncology, 1985 - 1988
  • Zhengzhou University
    Zhengzhou UniversityClass of 1983

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2007 - 2025
  • OH State Medical License
    OH State Medical License 2007 - 2024
  • NY State Medical License
    NY State Medical License 2004 - 2019
  • KY State Medical License
    KY State Medical License 2016 - 2017
  • MI State Medical License
    MI State Medical License 2006 - 2010
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Young Investigator Award American Association for Cancer, 1999
  • Award, Poster Presentation American Society of Hematology, 1997
  • Japanese Government Scholarships 1991, 1992, 1993, 1994, 1995, 1996
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study.  
    Ishizawa, K., Komori, T., Okayama, K., Qin, X., Kaneko, K., Sasaki, S. and Iwata, M, Acta Neuropathol (Berl) 97:63-70
  • Reduced lung tumorigenesis in human MGMT transgenic mice achieved by expression of transgene within the target cell.  
    Liu, L., Qin, X. and Gerson, SL, Carcinogenesis, 20:179-284
  • Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.  
    Qin, X., Liu, L. and Gerson, SL, Oncogene, 18:4394-4400
  • Join now to see all

Books/Book Chapters

Hospital Affiliations